Dataset Open Access

Virtual screening of 2629 Janssen compounds against SARS-CoV-2 RdRP

Van Damme, Ellen

This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 RdRP and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.

Files (147.0 kB)
Name Size
Virtual screening of 2629 Janssen compounds against SARS-CoV-2 RdRP.xlsx
md5:c28690e52a0a60cd265be6fe4ae230e4 		147.0 kB Download
118
4
views
downloads
All versions This version
Views 118118
Downloads 44
Data volume 588.2 kB588.2 kB
Unique views 113113
Unique downloads 44
More info on how stats are collected.
Indexed in
Publication date:
January 11, 2022
DOI:
10.5281/zenodo.5838690

Zenodo DOI Badge

DOI 

10.5281/zenodo.5838690

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.5838690.svg)](https://doi.org/10.5281/zenodo.5838690)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.5838690.svg
   :target: https://doi.org/10.5281/zenodo.5838690

HTML 

<a href="https://doi.org/10.5281/zenodo.5838690"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.5838690.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.5838690.svg

Target URL 

https://doi.org/10.5281/zenodo.5838690

Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.5838690 Jan 11, 2022
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.5838689. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export